Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany

MLA

E. Dornstauder, et al. “Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany.” Advances in Therapy, vol. 38, no. 5, Apr. 2021, pp. 2532–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5f874050a1f81d6b5dcbf2eae709094&authtype=sso&custid=ns315887.

APA

E. Dornstauder, Bondo Monga, Ingo Ahrens, Artak Khachatryan, & Eduard Sidelnikov. (2021). Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany. Advances in Therapy, 38(5), 2532–2541.

Chicago

E. Dornstauder, Bondo Monga, Ingo Ahrens, Artak Khachatryan, and Eduard Sidelnikov. 2021. “Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany.” Advances in Therapy 38 (5): 2532–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c5f874050a1f81d6b5dcbf2eae709094&authtype=sso&custid=ns315887.